Surgical Equipment Financing: OR Tables, Lights, Robots, and Instruments

The ambulatory surgery center (ASC) market has been growing steadily for a decade. Lower overhead than hospital ORs, better patient experience, and physician ownership structures that align incentives — ASCs have become the preferred venue for a wide range of elective and semi-elective surgical procedures.

Dr. Michael Chen and two surgical partners opened their orthopedic-focused ASC outside of Denver four years ago. The initial equipment buildout — two operating rooms, sterilization, recovery — cost $1.8 million. Their most recent equipment addition was a surgical navigation system for joint replacement work that competing ASCs were now offering to attract surgeons.

The navigation system: Stryker Mako robotic arm assistance system — $1.1 million installed. Alternatively, a Smith+Nephew CORI robotic system at $850,000.

How surgical equipment gets financed at this level is a specific enough subject to deserve its own treatment.

The Surgical Equipment Categories

Operating room tables ($25,000–$120,000): Steris Amsco surgical tables, Trumpf Medical TruSystem, Skytron — these are the foundational OR infrastructure. Carbon fiber radiolucent tables with full imaging compatibility for orthopedic work run $70,000–$120,000. Specialty tables (spine, cardiac, bariatric) are at the higher end. Well-understood medical equipment with active secondary markets.

Surgical lighting ($20,000–$80,000 per OR): Stryker Stellar, Berchtold, Trumpf Medical, Skytron — modern LED surgical lighting with integration capability. Full OR lighting packages are often financed as part of a room buildout project.

Laparoscopic and endoscopic equipment ($40,000–$150,000 per system): Karl Storz, Stryker 1588 AIM, Olympus VISERA ELITE — high-definition camera systems, light sources, insufflators, and integrated OR management systems. Technology refresh cycle is 5–7 years for the core systems.

Robotic surgery systems ($500,000–$2.5M+): Intuitive Surgical da Vinci (the market leader at $1.5–$2.5M for the newest Xi platforms), Stryker Mako (orthopedic robotics, $1–1.5M), Zimmer Biomet ROSA ($500,000–$900,000), Smith+Nephew CORI ($700,000–$1M) — these are the highest-profile surgical equipment investments and deserve separate treatment.

Instrument sets ($15,000–$80,000 per set): Orthopedic implant system instrument sets, laparoscopic instrument sets — these are often leased from implant companies (consignment lending against implant purchasing commitment) rather than financed as standalone equipment.

Robotic Surgery Systems: The Highest-Stakes Surgical Equipment Decision

A robotic surgery system is a fundamentally different kind of equipment finance decision from most surgical equipment. Here's why:

The platform lock-in is real. Surgeons who train on da Vinci don't cross-train on Stryker Mako and vice versa. The robotic surgery system you finance determines your surgeon credentialing path and your implant system relationships for the life of the asset. This is a business strategy decision, not just a capital equipment decision.

Revenue depends on case volume. A robotic system's ROI is entirely dependent on case volume and procedure mix. An ASC financing a Stryker Mako at $1.1M/year payment needs to perform enough joint replacement cases to cover the payment from the per-case margin improvement. The break-even analysis must be done before financing, not after.

Service contracts are mandatory and expensive. Da Vinci service contracts from Intuitive Surgical run $100,000–$180,000/year. Stryker Mako service contracts are similarly priced. These costs must be in your cash flow model alongside the financing payment.

Leasing often makes sense for robotics. The technology refresh cycle is 5–7 years for surgical robotics platforms, and later-generation systems offer meaningfully better capabilities. An FMV lease at 60–72 months positions you for a technology decision at term end rather than owning a 6-year-old robotic system.

Healthcare Equipment Financing: What ASCs Need

ASCs have specific financial characteristics that the right lender understands:

• Revenue is procedure-based and relatively predictable (surgical case volume)
• Case mix and payer mix (commercial insurance, Medicare, patient pay) affect revenue per procedure
• Tax-exempt financing is available for non-profit-affiliated ASCs
• Healthcare-specific lenders understand AAAHC/Joint Commission accreditation and what it signals

Standard application for an ASC equipment purchase:

• 2 years of ASC tax returns or financial statements
• Current operational statistics (monthly case volume, procedure mix)
• Existing ASC license and accreditation documentation
• Equipment quote with complete installation and training scope

For robotic surgery systems, lenders who have placed Stryker, Intuitive, or Zimmer systems before understand the service contract structure and the business model. Generalist lenders who have never seen a surgical robotics application will slow you down.

2026 Rate Ranges for Surgical Equipment

Strong borrowers (established ASC or hospital system, 700+ FICO equivalent):

• New OR tables and lighting (standard): 7%–10%
• New laparoscopic/endoscopic systems: 7.5%–10.5%
• New robotic surgery systems: 8%–12%
• FMV lease on robotic systems: rate-equivalent 8%–11%

Mid-tier (smaller ASC, startup, or new practice):

• New standard surgical equipment: 10%–14%
• Robotic systems at this tier: require established case volume projections and strong personal financial strength

Terms: Standard OR equipment: 60–84 months. Laparoscopic systems: 48–60 months (technology cycle consideration). Robotic systems: 60–84 months for loan; 48–72 months FMV lease is common.

Dr. Chen's Decision

Profile: 4-year-old ASC, $5.2 million in revenue, strong payer mix (62% commercial), 728 FICO on the business, three-physician ownership.

They chose the Stryker Mako at $1.1M over the less expensive ROSA system because the partnership agreement with their orthopedic implant supplier included favorable pricing on Stryker implants (a volume-based discount that partially offset the equipment cost premium).

Structure: 60-month FMV lease.

Monthly payment: approximately $20,800

Case volume projection for Mako: 8–12 joint replacement cases per month at an average margin improvement of $1,800–$2,400/case over manual technique (from reduced OR time and implant selection). Monthly margin improvement: $14,400–$28,800. Sufficient to cover the payment, with the additional benefit of attracting two fellowship-trained joint replacement surgeons who had been considering the competing hospital system that already had Mako.

Get a quote for surgical equipment financing. We work with healthcare-focused lenders who understand ASC operations, OR buildouts, and robotic surgery system financing.